Kaya Holdings, Inc. (KAYS)
| Previous Close | 0.0304 |
| Open | 0.0304 |
| Bid | 0.0303 x 0 |
| Ask | 0.0389 x 0 |
| Day's Range | 0.0304 - 0.0304 |
| 52 Week Range | 0.0280 - 0.0540 |
| Volume | |
| Avg. Volume | 3,910 |
| Market Cap | 674,053 |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 3.04 |
| EPS (TTM) | 0.0100 |
| Earnings Date | Nov 22, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACCESSWIREThe Sacred Mushroom(TM) Psilocybin Center Operated by Kaya Holdings, Inc. (OTCQB:KAYS) Releases First E-Book
"Is Psilocybin Right for You" is the first in a planned series of helpful e-books about psilocybin. FT. LAUDERDALE, FL / ACCESSWIRE / October 2, 2024 / The Sacred Mushroom™ ("TSM"), an emerging leader in the delivery of psilocybin experiences at its ...
ACCESSWIREKaya Holdings, Inc. (OTCQB:KAYS) Criticizes FDA Rejection of MDMA Therapy for PTSD, Proposes Psilocybin as Alternative Treatment
FT. LAUDERDALE, FL / ACCESSWIRE / August 13, 2024 /Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), a "mind care" company with operations in the emerging psilocybin treatment sector and in medical/recreational cannabis, criticized the ...
- ACCESSWIRE
Kaya Holdings, Inc. Announces Grand Opening of The Sacred Mushroom, Oregon's Premier Psilocybin Center
KAYS CEO Craig Frank to receive The Sacred Mushroom's first Psilocybin Treatment FT. LAUDERDALE, FL / ACCESSWIRE / July 2, 2024 / Kaya Holdings, Inc. ("KAYS" or the "Company") (OTCQB:KAYS), announced today that its licensed psilocybin treatment center ...
